tiprankstipranks
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ:VNDA

Vanda (VNDA) Income Statement

362 Followers

Vanda Income Statement

Last quarter (Q4 2023), Vanda's total revenue was $45.27M, a decrease of -29.79% from the same quarter last year. In Q4, Vanda's net income was $-2.33M. See Vanda’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 192.64M$ 192.64M$ 254.38M$ 268.68M$ 248.17M$ 227.19M
Cost of Revenue
$ 10.02M$ 14.80M$ 24.28M-$ 23.36M$ 24.49M
Gross Profit
$ 182.62M$ 177.84M$ 230.10M$ 268.68M$ 224.80M$ 202.70M
Operating Expense
$ 191.80M$ 191.80M$ 223.77M$ 200.89M$ 197.56M$ 179.89M
Operating Income
$ -9.22M$ -13.95M$ 6.33M$ 67.79M$ 27.24M$ 22.81M
Net Non Operating Interest Income Expense
---$ -25.63M--
Other Income Expense
$ -15.52M$ -20.29M$ -4.97M$ -199.00K$ 4.42M$ 6.22M
Pretax Income
$ 6.34M$ 6.34M$ 11.30M$ 42.36M$ 31.66M$ 29.03M
Tax Provision
$ 3.83M$ 3.83M$ 5.03M$ 9.21M$ 8.32M$ -86.53M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 2.56M$ 2.51M$ 6.28M$ 33.15M$ 23.34M$ 115.55M
Basic EPS
$ 0.05$ 0.04$ 0.11$ 0.60$ 0.43$ 2.17
Diluted EPS
$ 0.05$ 0.04$ 0.11$ 0.58$ 0.42$ 2.11
Basic Average Shares
$ 229.52M$ 57.38M$ 56.46M$ 55.55M$ 54.43M$ 53.14M
Diluted Average Shares
$ 230.23M$ 57.56M$ 56.98M$ 56.92M$ 55.19M$ 54.85M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 201.82M$ 206.59M$ 248.05M$ 200.89M$ 220.93M$ 204.38M
Net Income From Continuing And Discontinued Operation
$ 2.51M$ 2.51M$ 6.28M$ 33.15M$ 23.34M$ 115.55M
Normalized Income
$ 315.49K$ 5.01M$ 8.93M-$ 23.34M$ 115.55M
Interest Expense
------
EBIT
$ 6.34M$ 6.34M$ 11.30M$ 42.36M$ 27.24M$ 22.81M
EBITDA
$ 8.95M$ 9.33M$ 14.02M$ 45.24M$ 30.10M$ 25.70M
Currency in USD

Vanda Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis